Medifast Inc
MED11.398USD
-0.452-3.81%
Horário de mercado （ET）Cotações atrasadas em 15 min
125.28MValor de mercado
498.16P/L TTM
Mais detalhes de Medifast Inc Empresa
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Informações de Medifast Inc
Código da empresaMED
Nome da EmpresaMedifast Inc
Data de listagemDec 30, 1993
CEOChard (Daniel R)
Número de funcionários504
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 30
Endereço100 International Drive, 18th Floor
CidadeBALTIMORE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal21202
Telefone14105818042
Sitehttps://medifastinc.com/
Código da empresaMED
Data de listagemDec 30, 1993
CEOChard (Daniel R)
Executivos da empresa Medifast Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Elizabeth A. Geary
Ms. Elizabeth A. Geary
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Detalhamento da receita
FY2025Q2
FY2025Q1
FY2024
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
105.56M
0.00%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: ter, 18 de nov
Atualizado em: ter, 18 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Outro
69.09%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Outro
69.09%
Tipos de investidores
Investidores
Proporção
Investment Advisor
34.59%
Investment Advisor/Hedge Fund
25.52%
Hedge Fund
17.51%
Research Firm
7.05%
Individual Investor
3.30%
Family Office
0.88%
Pension Fund
0.13%
Bank and Trust
0.12%
Insurance Company
0.03%
Outro
10.85%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
470
8.80M
80.10%
-3.51M
2025Q2
501
8.65M
78.71%
-4.63M
2025Q1
543
8.84M
80.44%
-4.55M
2024Q4
558
9.50M
86.82%
-4.11M
2024Q3
566
9.73M
88.98%
-4.84M
2024Q2
601
11.02M
100.79%
-3.10M
2024Q1
608
12.20M
111.59%
-579.67K
2023Q4
629
10.91M
100.15%
-1.24M
2023Q3
641
10.20M
93.63%
-1.89M
2023Q2
664
10.18M
93.46%
-1.94M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
799.27K
7.27%
-56.13K
-6.56%
Jun 30, 2025
Renaissance Technologies LLC
813.31K
7.4%
-75.62K
-8.51%
Jun 30, 2025
The Vanguard Group, Inc.
795.45K
7.24%
+31.89K
+4.18%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
421.17K
3.83%
+155.60K
+58.59%
Jun 30, 2025
BofA Global Research (US)
396.37K
3.61%
+107.85K
+37.38%
Jun 30, 2025
Two Sigma Investments, LP
419.02K
3.81%
-16.70K
-3.83%
Jun 30, 2025
Acadian Asset Management LLC
411.10K
3.74%
+25.38K
+6.58%
Jun 30, 2025
Parametric Portfolio Associates LLC
323.67K
2.94%
+108.94K
+50.73%
Jun 30, 2025
AQR Capital Management, LLC
220.13K
2%
+20.38K
+10.20%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
Acquirers Small and Micro Deep Value ETF
0.79%
Federated Hermes MDT Small Cap Core ETF
0.19%
First Trust Active Factor Small Cap ETF
0.15%
iShares US Small Cap Value Factor ETF
0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.12%
Schwab Fundamental U.S. Small Company ETF
0.06%
iShares US Small-Cap Equity Factor ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.02%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Ver Mais
Acquirers Small and Micro Deep Value ETF
Proporção0.79%
Federated Hermes MDT Small Cap Core ETF
Proporção0.19%
First Trust Active Factor Small Cap ETF
Proporção0.15%
iShares US Small Cap Value Factor ETF
Proporção0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporção0.12%
Schwab Fundamental U.S. Small Company ETF
Proporção0.06%
iShares US Small-Cap Equity Factor ETF
Proporção0.04%
Franklin US Small Cap Multifactor Index ETF
Proporção0.02%
iShares Micro-Cap ETF
Proporção0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.02%
Dividendo
Um total de
262.40M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sep 07, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Nov 07, 2023 going ex on Sep 18, 2023
Sep 19, 2023
Nov 07, 2023
Sep 18, 2023
Jun 15, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Aug 08, 2023 going ex on Jun 26, 2023
Jun 27, 2023
Aug 08, 2023
Jun 26, 2023
Mar 16, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on May 09, 2023 going ex on Mar 27, 2023
Mar 28, 2023
May 09, 2023
Mar 27, 2023
Dec 08, 2022
MED.NB Final Cash Dividend of gross USD 1.64 paid on Feb 07, 2023 going ex on Dec 19, 2022
Dec 20, 2022
Feb 07, 2023
Dec 19, 2022
Sep 08, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Nov 08, 2022 going ex on Sep 19, 2022
Sep 20, 2022
Nov 08, 2022
Sep 19, 2022
Jun 16, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 08, 2022 going ex on Jun 27, 2022
Jun 28, 2022
Aug 08, 2022
Jun 27, 2022
Mar 17, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on May 09, 2022 going ex on Mar 28, 2022
Mar 29, 2022
May 09, 2022
Mar 28, 2022
Dec 08, 2021
MED.NB Final Cash Dividend of gross USD 1.42 paid on Feb 08, 2022 going ex on Dec 20, 2021
Dec 21, 2021
Feb 08, 2022
Dec 20, 2021
Sep 09, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Nov 08, 2021 going ex on Sep 20, 2021
Sep 21, 2021
Nov 08, 2021
Sep 20, 2021
Jun 03, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Aug 06, 2021 going ex on Jun 21, 2021
Jun 22, 2021
Aug 06, 2021
Jun 21, 2021
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de Medifast Inc?
Os cinco principais acionistas de Medifast Inc são:
BlackRock Institutional Trust Company, N.A. detém 799.27K Ações, representando 7.27% do total de Ações.
Renaissance Technologies LLC detém 813.31K Ações, representando 7.40% do total de Ações.
The Vanguard Group, Inc. detém 795.45K Ações, representando 7.24% do total de Ações.
Charles Schwab Investment Management, Inc. detém 421.17K Ações, representando 3.83% do total de Ações.
BofA Global Research (US) detém 396.37K Ações, representando 3.61% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 799.27K Ações, representando 7.27% do total de Ações.
Renaissance Technologies LLC detém 813.31K Ações, representando 7.40% do total de Ações.
The Vanguard Group, Inc. detém 795.45K Ações, representando 7.24% do total de Ações.
Charles Schwab Investment Management, Inc. detém 421.17K Ações, representando 3.83% do total de Ações.
BofA Global Research (US) detém 396.37K Ações, representando 3.61% do total de Ações.
Quais são os três principais tipos de acionistas de Medifast Inc?
Os três principais tipos de acionistas da Medifast Inc são:
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
Quantas instituições possuem ações da Medifast Inc (MED)?
Em 2025Q3, 470 instituições possuíam ações da Medifast Inc, com valor de mercado aproximado de 8.80M, representando 80.10% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em 1.39%.
Qual é a maior fonte de receita da Medifast Inc?
Em FY2025Q2, o segmento de negócios -- gerou a maior receita para Medifast Inc, totalizando -- e representando --% da receita total.
